Home/Vivani Medical/Adam Mendelsohn, Ph.D.
AM

Adam Mendelsohn, Ph.D.

Co-Founder & Chief Executive Officer

Vivani Medical

Vivani Medical Pipeline

DrugIndicationPhase
NPM-139Chronic Weight Management (Obesity/Overweight)Preclinical
NPM-133Type 2 DiabetesPreclinical
NPM-115Type 2 Diabetes (Proof-of-Concept)Phase 1